OTX-2002
- Generic Name
- OTX-2002
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
OTX-2002 is a bicistronic messenger ribonucleic acid (mRNA) encoding for ZF-DNMT and ZF-KRAB proteins, encapsulated in a lipid nanoparticle (LNP).
- Associated Conditions
- -
- Associated Therapies
- -
Omega Therapeutics Stock Hits 52-Week Low at $0.74
Omega Therapeutics' stock hits a 52-week low at $0.74, an 88% drop from its high, amid financial struggles and a high debt-to-equity ratio. Despite challenges, analysts see potential upside, with price targets up to $12. The company reports promising Phase I study results, board changes, and partnerships, including with Novo Nordisk for obesity treatment development.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath